|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Massachusetts Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing MassachusettsLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Boston Therapeutics, Inc.
| | | Phone: | (603) 935-9799 | Year Established: | 2009 | Ticker: | BTHE | Exchange: | OTCQB | Main Contact: | Carl Rausch, CEO | | Other Contacts: | Loraine V. Upham, COO Stephen Spanos, Acting CFO
| | Company Description | Boston Therapeutics is an innovator in designing compounds using complex carbohydrate chemistry. The company's product pipeline is focused on developing and commercializing therapeutic molecules that address diabetes and inflammatory diseases, including: BTI-320, a non-systemic chewable therapeutic compound designed to reduce HbA1C. | |
|
|
|
|
|